{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:36:01Z","timestamp":1792074961405,"version":"4.4.0"},"reference-count":45,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0049","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:47:17Z","timestamp":1717505237000},"source":"Crossref","is-referenced-by-count":6,"title":["Decision coaching for healthy women with BRCA1\/2 pathogenic variants\u2014findings of the randomized controlled EDCP-BRCA trial"],"prefix":"10.3238","author":[{"given":"Stephanie","family":"Stock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Isselhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arim","family":"Shukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Kautz-Freimuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Reda\u00e8lli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Berger-H\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dikow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Kiechle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"K\u00f6berlein-Neu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Schmutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Steckelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion Tina","family":"van Mackelenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vitinius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"W\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"10.3238\/arztebl.m2024.0049_ref1","unstructured":"Kast K, Rhiem K, Wappenschmidt B, et al.: Prevalence of BRCA1\/2 germline mutations in 21401 families with breast and ovarian cancer. J Med Genet 2016; 53: 465–71."},{"key":"10.3238\/arztebl.m2024.0049_ref2","doi-asserted-by":"crossref","unstructured":"Hauke J, Horvath J, Gro\u00df E, et al.: Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med 2018; 7: 1349–58.","DOI":"10.1002\/cam4.1376"},{"key":"10.3238\/arztebl.m2024.0049_ref3","doi-asserted-by":"crossref","unstructured":"Rhiem K, B\u00fccker-Nott H, Hellmich M, et al.: Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J 2019; 25: 455–60.","DOI":"10.1111\/tbj.13257"},{"key":"10.3238\/arztebl.m2024.0049_ref4","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al.: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017; 317: 2402–16."},{"key":"10.3238\/arztebl.m2024.0049_ref5","doi-asserted-by":"crossref","unstructured":"Bick U, Engel C, Krug B, et al. on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC): High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 2019; 175: 217–28.","DOI":"10.1007\/s10549-019-05152-9"},{"key":"10.3238\/arztebl.m2024.0049_ref6","doi-asserted-by":"crossref","unstructured":"De Felice F, Marchetti C, Musella A, et al.: Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol 2015; 22: 2876–80.","DOI":"10.1245\/s10434-015-4532-1"},{"key":"10.3238\/arztebl.m2024.0049_ref7","doi-asserted-by":"crossref","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB, et al.: Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2019; 177: 723–33.","DOI":"10.1007\/s10549-019-05345-2"},{"key":"10.3238\/arztebl.m2024.0049_ref8","doi-asserted-by":"crossref","unstructured":"Li X, You R, Wang X, et al.: Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res 2016; 22: 3971–81.","DOI":"10.1158\/1078-0432.CCR-15-1465"},{"key":"10.3238\/arztebl.m2024.0049_ref9","doi-asserted-by":"crossref","unstructured":"Rebbeck TR, Kauff ND, Domchek SM: Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009; 101: 80–7.","DOI":"10.1093\/jnci\/djn442"},{"key":"10.3238\/arztebl.m2024.0049_ref10","doi-asserted-by":"crossref","unstructured":"Domchek SM, Friebel TM, Singer CF, et al.: Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010; 304: 967–75.","DOI":"10.1001\/jama.2010.1237"},{"key":"10.3238\/arztebl.m2024.0049_ref11","doi-asserted-by":"crossref","unstructured":"De Felice F, Marchetti C, Boccia SM, et al.: Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know. Cancer Treat Rev 2017; 61: 1–5.","DOI":"10.1016\/j.ctrv.2017.09.005"},{"key":"10.3238\/arztebl.m2024.0049_ref12","doi-asserted-by":"crossref","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, et al.: Decision aids for people facing health treatment or screening decisions. Cochrane Database of Syst Rev 2017, Issue 4. Art. No.: CD001431.","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"10.3238\/arztebl.m2024.0049_ref13","doi-asserted-by":"crossref","unstructured":"Stacey D, Kryworuchko J, Bennett C, Murray MA, Mullan S, L\u00e9gar\u00e9 F: Decision coaching to prepare patients for making health decisions: a systematic review of decision coaching in trials of patient decision aids. Med Decis Making 2012; 32: E22–33.","DOI":"10.1177\/0272989X12443311"},{"key":"10.3238\/arztebl.m2024.0049_ref14","doi-asserted-by":"crossref","unstructured":"Jull J, K\u00f6pke S, Smith M, et al.: Decision coaching for people making healthcare decisions. Cochrane Database Syst Rev 2021 (11): CD013385.","DOI":"10.1002\/14651858.CD013385.pub2"},{"key":"10.3238\/arztebl.m2024.0049_ref15","doi-asserted-by":"crossref","unstructured":"Hahlweg P, Kriston L, Scholl I, et al.: Cancer patients’ preferred and perceived level of involvement in treatment decision-making: an epidemiological study. Acta Oncol 2020; 59: 967–74.","DOI":"10.1080\/0284186X.2020.1762926"},{"key":"10.3238\/arztebl.m2024.0049_ref16","doi-asserted-by":"crossref","unstructured":"Noteboom EA, May AM, van der Wall E, de Wit NJ, Helsper CW: Patients’ preferred and perceived level of involvement in decision making for cancer treatment: a systematic review. Psychooncology 2021; 30: 1663–79.","DOI":"10.1002\/pon.5750"},{"key":"10.3238\/arztebl.m2024.0049_ref17","doi-asserted-by":"crossref","unstructured":"Isselhard A, T\u00f6pper M, Berger-H\u00f6ger B, et al.: Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1\/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study. Trials 2020; 21: 501.","DOI":"10.1186\/s13063-020-04431-x"},{"key":"10.3238\/arztebl.m2024.0049_ref18","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D; CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18.","DOI":"10.1186\/1741-7015-8-18"},{"key":"10.3238\/arztebl.m2024.0049_ref19","doi-asserted-by":"crossref","unstructured":"Berger-H\u00f6ger B, Liethmann K, M\u00fchlhauser I, Steckelberg A: Implementation of shared decision-making in oncology: development and pilot study of a nurse-led decision-coaching programme for women with ductal carcinoma in situ. BMC Med Inform Decis Mak 2017; 17: 160.","DOI":"10.1186\/s12911-017-0548-8"},{"key":"10.3238\/arztebl.m2024.0049_ref20","doi-asserted-by":"crossref","unstructured":"Berger-H\u00f6ger B, Vitinius F, Fischer H, et al.: Nurse-led decision coaching by specialized nurses for healthy BRCA1\/2 gene mutation carriers—adaptation and pilot testing of a curriculum for nurses: a qualitative study. BMC Nurs 2022; 21: 42.","DOI":"10.1186\/s12912-022-00810-8"},{"key":"10.3238\/arztebl.m2024.0049_ref21","doi-asserted-by":"crossref","unstructured":"Vitinius F, Sonntag B, Barthel Y, et al.: KoMPASS—Konzeption, Implementierung und Erfahrungen mit einem strukturierten Kommunikationstraining f\u00fcr onkologisch t\u00e4tige \u00c4rzte. Psychother Psych Med 2013; 63: 482–8.","DOI":"10.1055\/s-0033-1341468"},{"key":"10.3238\/arztebl.m2024.0049_ref22","doi-asserted-by":"crossref","unstructured":"Kautz-Freimuth S, Reda\u00e8lli M, Rhiem K, et al.: Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making. BMC Med Inform Decis Mak 2021; 21: 180.","DOI":"10.1186\/s12911-021-01528-4"},{"key":"10.3238\/arztebl.m2024.0049_ref23","doi-asserted-by":"crossref","unstructured":"Kautz-Freimuth S, Reda\u00e8lli M, Isselhard A, et al.: Evaluation of two evidence-based decision aids for female BRCA1\/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial. Trials 2022; 23: 157.","DOI":"10.1186\/s13063-022-06081-7"},{"key":"10.3238\/arztebl.m2024.0049_ref24","doi-asserted-by":"crossref","unstructured":"Kautz-Freimuth S, Reda\u00e8lli M, Shukri A, et al.: Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial. BMC Med Inform Decis Mak 2023; 23: 223.","DOI":"10.1186\/s12911-023-02327-9"},{"key":"10.3238\/arztebl.m2024.0049_ref25","doi-asserted-by":"crossref","unstructured":"Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K: Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol 2010; 21: 1145–51.","DOI":"10.1093\/annonc\/mdp534"},{"key":"10.3238\/arztebl.m2024.0049_ref26","doi-asserted-by":"crossref","unstructured":"Degner LF, Sloan JA, Venkatesh P: The control preferences scale. Can J Nurs Res 1997; 29: 21–43.","DOI":"10.1037\/t22188-000"},{"key":"10.3238\/arztebl.m2024.0049_ref27","doi-asserted-by":"crossref","unstructured":"Brown R, Butow P, Wilson-Genderson M, Bernhard J, Ribi K, Juraskova I: Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes. J Clin Oncol 2012; 30: 857–62.","DOI":"10.1200\/JCO.2011.37.7952"},{"key":"10.3238\/arztebl.m2024.0049_ref28","doi-asserted-by":"crossref","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175–91.","DOI":"10.3758\/BF03193146"},{"key":"10.3238\/arztebl.m2024.0049_ref29","unstructured":"Team RC: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2023."},{"key":"10.3238\/arztebl.m2024.0049_ref30","doi-asserted-by":"crossref","unstructured":"Brom L, De Snoo-Trimp JC, Onwuteaka-Philipsen BD, Widdershoven GAM, Stiggelbout AM, Pasman HRW: Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study. Health Expect 2017; 20: 69–84.","DOI":"10.1111\/hex.12434"},{"key":"10.3238\/arztebl.m2024.0049_ref31","doi-asserted-by":"crossref","unstructured":"Kunneman M, Marijnen CAM, Baas-Thijssen MCM, et al.: Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making. Radiother Oncol 2015; 117: 338–42.","DOI":"10.1016\/j.radonc.2015.09.005"},{"key":"10.3238\/arztebl.m2024.0049_ref32","doi-asserted-by":"crossref","unstructured":"O’Brien MA, Ellis PM, Whelan TJ, et al.: Physician-related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients. Health Expect 2013; 16: 373–84.","DOI":"10.1111\/j.1369-7625.2011.00712.x"},{"key":"10.3238\/arztebl.m2024.0049_ref33","doi-asserted-by":"crossref","unstructured":"L\u00e9gar\u00e9 F, Ratt\u00e9 S, Gravel K, Graham ID: Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns 2008; 73: 526–35.","DOI":"10.1016\/j.pec.2008.07.018"},{"key":"10.3238\/arztebl.m2024.0049_ref34","doi-asserted-by":"crossref","unstructured":"Keating NL, Beth Landrum M, Arora NK, et al.: Cancer patients’ roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol 2010; 28: 4364–70.","DOI":"10.1200\/JCO.2009.26.8870"},{"key":"10.3238\/arztebl.m2024.0049_ref35","doi-asserted-by":"crossref","unstructured":"Giersdorf N, Loh A, Bieber C, et al.: Arbeitsgruppe Methoden des BMGS-F\u00f6rderschwerpunktes „Der Patient als Partner im medizinischen Entscheidungsprozess“. 2004. Development and validation of assessment instruments for shared decision making. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 47, 969–976. https:\/\/doi.org\/10.1007\/s00103-004-0905-5 (last accessed on 15 April 2024).","DOI":"10.1007\/s00103-004-0905-5"},{"key":"10.3238\/arztebl.m2024.0049_ref36","unstructured":"O’Connor A: User manual—decisional conflict scale. Ottawa Hospital Research Institute, Ottawa, Canada 1993. Updated 2010. Available from http:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Decisional_Conflict.pdf (last accessed on 19 September 2023)."},{"key":"10.3238\/arztebl.m2024.0049_ref37","unstructured":"Buchholz A, H\u00f6lzel L, Kriston L, Simon D, H\u00e4rter M: Die Decisional Conflict Scale in deutscher Sprache (DCS-D)—Dimensionale Struktur in einer Stichprobe von Hausarztpatienten. Klin Diagn Eval 2011; 4: 15–30."},{"key":"10.3238\/arztebl.m2024.0049_ref38","unstructured":"O’Connor A, Grant F: User manual—stage of decision making scale. Ottawa Hospital Research Institute, Ottawa, Canada 2000. https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Stage_Decision_Making.pdf (last accessed on 1 December 2020)."},{"key":"10.3238\/arztebl.m2024.0049_ref39","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWIG). Entscheidungshilfe. GesundheitsinformationDe 2013. www.gesundheitsinformation.de\/pdf\/entscheidungshilfe\/entscheidungshilfe_interaktiv.pdf (last accessed on 1 December 2020)."},{"key":"10.3238\/arztebl.m2024.0049_ref40","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"10.3238\/arztebl.m2024.0049_ref41","unstructured":"Herrmann-Lingen C, Buss U, Snaith R: HADS-D. Hospital Anxiety and Depression Scale—Deutsche Version. Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R.P. Snaith und A.S. Zigmond. 3rd ed. Bern: Huber 2011."},{"key":"10.3238\/arztebl.m2024.0049_ref42","doi-asserted-by":"crossref","unstructured":"Hinz A, Br\u00e4hler E: Normative values for the Hospital Anxiety and Depression Scale (HADS) in the general German population. J Psychosom Res 2011; 71: 74–8.","DOI":"10.1016\/j.jpsychores.2011.01.005"},{"key":"10.3238\/arztebl.m2024.0049_ref43","doi-asserted-by":"crossref","unstructured":"Weiss D, Marmar C: The Impact of event scale—revised. Wilson JP, Terence WM. Assessing psychological trauma and PTSD, New York: Guilford Press 1997, 399–411.","DOI":"10.1037\/t12199-000"},{"key":"10.3238\/arztebl.m2024.0049_ref44","unstructured":"Maercker A, Sch\u00fctzwohl M: Erfassung von psychischen Belastungsfolgen: Die Impact of Event Skala—revidierte Version. Diagnostica 1998; 44: 130–41."},{"key":"10.3238\/arztebl.m2024.0049_ref45","unstructured":"Maerker A, Sch\u00fctzwohl M: IES-R 2019. www.psychologie.uzh.ch\/dam\/jcr:211930d4–83bd-405a-9dc2–66b7dfbacc66\/IES-R_Fragebogen_Auswertung.pdf (last accessed on 30 October 2019)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:53:12Z","timestamp":1717505592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0049","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}